Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-19T11:50:29.217Z Has data issue: false hasContentIssue false
  • English
  • Français

Carbamazepine-Induced Systemic Lupus Erythematosus

Published online by Cambridge University Press:  02 January 2018

St. Schmidt ,
M. Welcker ,
W. Greil  and
M. Schattenkirchner
M. Welcker
Affiliation:
Psychiatrische Klinik, University of Munich, Nußbaumstr. 7, D-8000 Munich 2, Germany
M. Schattenkirchner
Affiliation:
Medizinische Poliklinik, University of Munich Pettenkoferstr. 8a, D-8000 Munich 2, Germany
Get access Rights & Permissions [Opens in a new window]

Abstract

A 21–year-old woman suffering from bipolar affective disorder developed systemic lupus erythematosus (SLE) with characteristic laboratory findings, 18 months after starting carbamazepine maintenance treatment. SLE receded after withdrawal of carbamazepine and treatment with anti-inflammatory drugs. Although both the spontaneous occurrence of SLE and the psychosis as a sign of CNS involvement of SLE cannot be excluded, SLE could be considered as an adverse effect of carbamazepine.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 161 , Issue 4 , October 1992 , pp. 560 - 561
Copyright
Copyright © 1992 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Alballa, S., Fritzler, M. & Davis, P. (1987) A case of drug induced lupus due to carbamazepine. Journal of Rheumatology, 14, 599–600.Google Scholar
Bateman, D. E. (1985) Carbamazepine induced systemic lupus erythematosus: case report. British Medical Journal, 291, 632–633.Google Scholar
De Giorgio, C. M., Rabinowicz, A. L. & Olivas, R. D. (1991) Carbamazepine-induced antinuclear antibodies and systemic lupus erythematosus-like syndrome. Epilepsia, 32, 128–129.Google Scholar
Drory, V. E., Yust, I. & Korczyn, A. D. (1989) Carbamazepine-induced systemic lupus erythematosus. Clinical Neuropharmacology, 12, 115–118.CrossRefGoogle ScholarPubMed
Kolstee, H. J. V. (1983) Een patient met lupus erythematosus disseminatus veroorzaakt door het gebruik van carbamazepine (Tegretol). Nederlandsch Tijdschrift vor Geneeskunde, 127, 1588–1590.Google ScholarPubMed
Lishman, W. A. (1990) Organic Psychiatry: The Psychological Consequences of Cerebral Disorders (2nd edn 1987, reprinted 1990). Oxford: Blackwell Scientific Publications.Google Scholar
Lovisetto, P., Mairano, D., Cargnino, M., et al (1985) Su un caso di lupus farmaco-indotto. Recenti Progressi in Medicina, 76, 84–86.Google Scholar
Maravic, M. V., Kessler, C., Wessel, K., et al (1990) Anti-epileptic drug-induced systemic lupus erythematosus. Epilepsia, 31, 229.Google Scholar
McNicholl, B. (1985) Carbamazepine induced systemic lupus erythematosus. British Medical Journal, 291, 1126.Google Scholar
Öner, A., Topaloglu, R., Besbas, N., et al (1990) Carbamazepine induced systemic lupus erythematosus. Another warning. Clinical Neurology and Neurosurgery, 92, 261–262.Google Scholar
Rabinowicz, A. L., Olivas, R. D. & DeGiorgio, C. M. (1990) Carbamazepine-induced SLE. Neurology, 40 (suppl. 1), 137.Google Scholar
Simpson, J. R. (1966) “Collagen disease” due to carbamazepine (Tegretol). British Medical Journal, 2, 1434.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.